A non-cardiomyocyte autonomous mechanism of cardioprotection involving the SLO1 BK channel - PubMed (original) (raw)

A non-cardiomyocyte autonomous mechanism of cardioprotection involving the SLO1 BK channel

Andrew P Wojtovich et al. PeerJ. 2013.

Abstract

Opening of BK-type Ca(2+) activated K(+) channels protects the heart against ischemia-reperfusion (IR) injury. However, the location of BK channels responsible for cardioprotection is debated. Herein we confirmed that openers of the SLO1 BK channel, NS1619 and NS11021, were protective in a mouse perfused heart model of IR injury. As anticipated, deletion of the Slo1 gene blocked this protection. However, in an isolated cardiomyocyte model of IR injury, protection by NS1619 and NS11021 was insensitive to Slo1 deletion. These data suggest that protection in intact hearts occurs by a non-cardiomyocyte autonomous, SLO1-dependent, mechanism. In this regard, an in-situ assay of intrinsic cardiac neuronal function (tachycardic response to nicotine) revealed that NS1619 preserved cardiac neurons following IR injury. Furthermore, blockade of synaptic transmission by hexamethonium suppressed cardioprotection by NS1619 in intact hearts. These results suggest that opening SLO1 protects the heart during IR injury, via a mechanism that involves intrinsic cardiac neurons. Cardiac neuronal ion channels may be useful therapeutic targets for eliciting cardioprotection.

Keywords: Cardiac neurons; Ischemia; Large conductance potassium channel; NS11021; NS1619; Preconditioning; Reperfusion.

PubMed Disclaimer

Figures

Figure 1

Figure 1. Representative left ventricular pressure traces from perfused hearts.

Traces are shown for wild-type (WT) and _Slo1_−/− hearts, in the presence of vehicle (Ctrl.), NS1619 or NS11021, as per the methods. Traces are compressed on the time (x) axis. The top and bottom boundaries of the black shaded area represent the systolic and diastolic pressures, respectively. The onset of ischemia (I) and reperfusion (R) are indicated by arrows. Scale bars on each trace represent 10 min. (_x_-axis) and 50 mmHg (_y_-axis).

Figure 2

Figure 2. SLO1 dependent protection of perfused mouse heart against ischemia-reperfusion (IR) injury.

Perfused FVB littermate WT (white symbols) and _Slo1_−/− (gray symbols) mouse hearts were subjected to IR injury. Where indicated, hearts were treated with NS1619 (5 µM) or NS11021 (500 nM) prior to ischemia. (A): Left-ventricular function was determined as rate pressure product (RPP; heart rate × left ventricular developed pressure) and expressed as percent of initial value. Statistical significance between groups was determined using a mixed-effects model. *p < 0.05 between NS11021 and control (IR alone), #p < 0.05 between NS1619 and control (IR alone). (B): Following IR protocols, hearts were sliced, stained with TTC and fixed to delineate live (red) from dead or infarcted tissue (white). Infarcts were quantified by planimetry and expressed as a percent of the area at risk (100% in this global ischemia model). Images above the graph show representative slices from each group. Within each group, individual values are on the left, and means ± SEM on the right (N = 7 for IR group and 6 for all other groups). *p < 0.05 between NS11021 and control (IR alone), #p < 0.05 between NS1619 and control (IR alone).

Figure 3

Figure 3. SLO1 independent protection of adult mouse cardiomyocytes against simulated ischemia-reperfusion (IR) injury.

Myocytes were isolated from adult littermate WT (white) and _Slo1_−/− (gray) mouse hearts, and used immediately in the model of IR injury. Where indicated, cells were treated with NS1619 (5 µM), NS11021 (500 nM) or diazoxide (DZX, 10 µM). Upon completion of the IR protocol, cell viability was measured via Trypan blue exclusion and expressed as a percent of control (viability in control normoxic groups was: WT 70 ± 3%, _Slo1_−/− 69 ± 4%). Experimental conditions are listed below the _x_-axis. Data are means ± SEM, with N for each group listed in parentheses at the base off each bar. Each N represents an independent cardiomyocyte preparation. *p < 0.05 vs. IR alone (ANOVA).

Figure 4

Figure 4. SLO1 independent K+ channel activity in isolated mouse heart mitochondria.

Mitochondria were isolated from littermate WT (white) and _Slo1_−/− (gray) mouse hearts and loaded with Tl+-sensitive fluorophore. Mitochondrial K+ channel activity in the presence of NS compounds was determined using the Tl+-flux assay. Data are presented as Δ fluorescence upon Tl+ addition to media. ATP was present to block the mKATP channel. The baseline Δ fluorescence (Ctrl, set to 100%) was 24.7 ± 2.3 and 24.9 ± 4.4 arbitrary units in WT (white bars) and _Slo1_−/− (gray bars), respectively. Experimental conditions are listed below the x_-axis. Data are means ±SEM, with N for each group listed in parentheses at the base off each bar. Each N represents an independent mitochondrial preparation. Control, ATP and ATP + Pax data are replicated between panels A and B for comparison *p < 0.05 vs. ATP, †_p < 0.05 vs. ATP + NS compound (ANOVA).

Figure 5

Figure 5. Blocking cardiac neuronal function blocks SLO1 dependent protection in the intact heart.

(A, B): Perfused FVB mouse hearts from WT animals were subjected to IR injury. Where indicated, hearts were treated with NS1619 (5 µM), atpenin A5 (AA5, 10 nM), or hexamethonium (Hex, 500 µM) as detailed in the methods. Left-ventricular function was determined as rate pressure product (RPP; heart rate x left ventricular developed pressure) and expressed as a percent of initial value. Data are split across two panels for clarity. Statistical significance between groups was determined using a mixed-effects model. *p < 0.05 vs. IR alone, #p < 0.05 vs. NS1619 + IR. (C): Following IR protocols, hearts were sliced, stained with TTC and fixed to delineate live (red) from dead or infarcted tissue (white). Infarcts were quantified by planimetry and expressed as a percent of the area at risk (100% in this global ischemia model). Images above the graph show representative slices from each group. Within each group, individual values are on the left, and means ±SEM on the right (N = 8 for IR, 7 for AA5 + IR, and 6 for all other groups). *p < 0.05 vs. IR alone, #p < 0.05 vs. NS1619 + IR.

Figure 6

Figure 6. Histochemical staining and functional activity of cardiac neurons.

Perfused FVB mouse hearts from WT animals were subjected to IR injury. Where indicated, hearts were treated with NS1619 (5 µM), atpenin A5 (AA5, 10 nM), hexamethonium (Hex, 500 µM), or combinations of NS1619 + Hex or AA5 + Hex, as detailed in the methods. Panels A–C show representative total heart histochemical acetylcholinesterase (AChE) staining following (A) control perfusion, (B) IR injury and (C) IR with NS1619 pre-treatment. Dorsal side of the heart is shown, with magnifications of boxed areas shown in right panels. (D): Functional activity of cardiac neurons was determined following the six IR protocols used in Fig. 3, via the injection of nicotine (100 µM) for 5 min. The peak heart rate increase was found at 2 min, followed by desensitization and subsequent decrease in heart rate. Data are means ±SEM. N for each group is shown in parentheses to the right of the legend. Each N represents an individual perfused heart. *p < 0.05 vs. IR (ANOVA).

Figure 7

Figure 7. Working model of SLO1 (in)dependent mechanisms of action in NS1619/NS11021 cardioprotection.

(A): In isolated cardiomyocytes the NS compounds induce cardioprotection independent of SLO1. The ‘target’ remains unclear but may include inhibition of respiration or the uncoupling of oxidative phosphorylation (see text for details). This mechanism is compatible with the lack of evidence for SLO1 in cardiomyocytes. (B): In the whole heart, cardioprotection by NS1619/NS11021 is dependent on SLO1 and is likely mediated via a cell non-autonomous mechanism, involving intrinsic cardiac neurons. A barrier is hypothesized to exist, possibly accounting for the inability of NS compounds to recruit the nonspecific target responsible for protection in myocytes. This explains the lack of ability of NS1619/NS11021 to protect the intact _Slo1_−/− heart. HEX = hexamethonium.

Similar articles

Cited by

References

    1. Aldakkak M, Stowe DF, Cheng Q, Kwok WM, Camara AK. Mitochondrial matrix K+ flux independent of large-conductance Ca2+-activated K+ channel opening. American Journal of Physiology – Cell Physiology. 2010;298:C530–C541. doi: 10.1152/ajpcell.00468.2009. - DOI - PMC - PubMed
    1. Aon MA, Cortassa S, Wei AC, Grunnet M, O’Rourke B. Energetic performance is improved by specific activation of K+ fluxes through KCa channels in heart mitochondria. Biochimica et Biophysica Acta. 2010;1797:71–80. doi: 10.1016/j.bbabio.2009.08.002. - DOI - PMC - PubMed
    1. Armour JA. Comparative effects of endothelin and neurotensin on intrinsic cardiac neurons in situ. Peptides. 1996;17:1047–1052. doi: 10.1016/0196-9781(96)00134-9. - DOI - PubMed
    1. Armour JA. Histamine-sensitive intrinsic cardiac and intrathoracic extracardiac neurons influence cardiodynamics. American Journal of Physiology. 1996;270:R906–R913. - PubMed
    1. Armour JA. Intrinsic cardiac neurons involved in cardiac regulation possess alpha 1-, alpha 2-, beta 1- and beta 2-adrenoceptors. Canadian Journal of Cardiology. 1997;13:277–284. - PubMed

LinkOut - more resources